FDA Drops Two-Trial Requirement: A New Era for Addiction Treatment Drug Development
In a landmark policy shift, the FDA announced it will approve new drugs based on a single rigorous trial plus confirmatory evidence—a change that could accelerate development of therapies for opioid use disorder, alcohol addiction, and stimulant dependence.
March 2, 202613 min read